Ghayda' Aldabet

Dr. Ghayda' Aldabet

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
SKSara Khaleel
Sara Khaleel
HAHamada M. A. Abdelaziz
Hamada M. A. Abdelaziz
MAMuhammad Alzweiri
Muhammad Alzweiri
NQNidal Qinna
Nidal Qinna
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Aluminum chloride (AlCl3) is widely used in experimental toxicology, particularly in rodent models of neurodegeneration, where its effects have been studied primarily in the central nervous system. However, experimental findings also indicate that chronic exposure is associated with changes across multiple peripheral organs, although these observations are often considered separately. In this review, we bring together evidence from different organ systems to examine aluminum toxicity from a broader perspective. Rather than focusing on isolated tissue-specific effects, we consider the extent to which reported findings may reflect overlapping molecular disturbances expressed across physiological systems. Within this context, organ-level outcomes are discussed as potentially related manifestations of shared underlying processes, while acknowledging variability in experimental conditions and model interpretation. To structure this synthesis, we outline a conceptual framework that links recurring molecular responses, system-level regulatory influences, and tissue-specific patterns of injury. This approach is intended to provide a more integrated way of organizing existing data rather than to establish a single unifying mechanism. Importantly, the pathological alterations discussed throughout this review are interpreted as experimentally observed toxicological manifestations of chronic AlCl3 exposure rather than evidence that aluminum constitutes a definitive etiological cause of Alzheimer’s disease. Overall, this review aims to complement existing neuro-focused interpretations of the AlCl3 model by situating it within a multi-organ context and highlighting areas where further integrative investigation may be warranted.

16 April 2026 in Biology
Verified
Journal Article
Open access
PDF file
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
SKSara Khaleel
Sara Khaleel
NQNidal Qinna
Nidal Qinna
MAMuhammad Alzweiri
Muhammad Alzweiri
GAGhayda' Aldabet
Ghayda' Aldabet
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Individual variability in spontaneous behavior emerges from coordinated physiological states, yet the organization of baseline behavioral dimensions and their systemic metabolic correlations remains insufficiently characterized in healthy animals. Here, exploratory activity and self-directed grooming were quantified during a standardized Y-maze session and integrated with plasma fatty-acid profiles measured by orthogonal dual-column GC-MS in 30 healthy male Sprague–Dawley rats distributed across four independent cohorts. Correlation structure and principal component analysis showed that plasma lipid profiles exhibit non-random, low-dimensional organization, resolving into coherent compositional states dominated by coordinated shifts between shorter-chain (C14–C16) and longer-chain (C18) fatty-acid species. Behavioral variables are similarly organized into constrained dimensions capturing exploratory engagement and grooming expression or timing. Integrated correlation analysis indicated that plasma fatty-acid-derived lipid states aligned systematically with behavioral organization at the multivariate level across cohorts, with C18-enriched profiles generally aligned with higher behavioral engagement and earlier grooming expression at the state level, while C14/C16-enriched profiles associated with reduced exploration and delayed grooming initiation, although the direction of individual lipid–behavior correlations showed cohort dependence consistent with the context-dependent behavior of compositional lipid variables within distinct but physiologically normal lipidomic states. These findings demonstrate that state-level, correlation-based multivariate analysis can reveal structured plasma lipidomic configurations and their correspondence to behavioral organization under physiological conditions, without inferring causal directionality or pathway activation.

20 April 2026 in Journal of the Indian Chemical Society
Verified
Journal Article
Closed access
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
SKSara Khaleel
Sara Khaleel
NQNidal Qinna
Nidal Qinna
MAMuhammed Alzweiri
Muhammed Alzweiri
GAGhayda' Aldabet
Ghayda' Aldabet
TATalal Ahmad Aburjai
Talal Ahmad Aburjai

16 July 2026 in Biology
Verified
Journal Article
Open access
PDF file
MAMuhammad Alzweiri
Muhammad Alzweiri
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
NQNidal Qinna
Nidal Qinna
GAGhayda' Aldabet
Ghayda' Aldabet
HAHeba Salah AbuShahla
Heba Salah AbuShahla
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Current experimental neurotoxicity research commonly relies on evaluating individual behavioral and biochemical endpoints, often without considering whether spontaneous behavior and lipid metabolism exhibit coordinated multivariate organization under toxicological stress. To address this question, the present study employed an integrative framework combining spontaneous behavioral profiling, targeted plasma fatty acid methyl ester (FAME) profiling, chemometric analyses, targeted assessment of cholinergic function, and permutation-based statistical validation in an AlCl3-induced rat model of neurotoxicity. Behavioral assessment was performed using the Y-maze, and multivariate organization was evaluated using covariance analyses, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), one-dimensional projection modeling, and nonparametric permutation testing (10,000 permutations). AlCl3 exposure was associated with early dose-related behavioral impairment at day 21 (ANOVA, p = 0.0006). In addition, both the measured fatty acid profiles and behavioral measures exhibited significant non-random multivariate organization, with progressive dose-related changes observed following AlCl3 exposure. Collectively, these findings suggest that neurotoxic exposure is associated with coordinated changes in the multivariate organization of measured fatty acid profiles, behavioral measures, and cholinergic function rather than isolated alterations in individual variables. Although confirmation in larger independent cohorts and broader molecular profiling remains warranted, the present findings support the use of multivariate organizational analysis as a complementary systems-level framework for investigating experimental neurotoxicity.

30 December 2025 in Applied Nano
Verified
Journal Article
Open access
PDF file
MHMarw Mohammad Helmy
Marw Mohammad Helmy
DADuaa Abuarqoub
Duaa Abuarqoub
MAMohammad Al-Natour
Mohammad Al-Natour
Abdolelah Ali JaradatAbdolelah Ali Jaradat
Abdolelah Ali Jaradat
NQNidal Qinna
Nidal Qinna
AAAbdalla Awidi
Abdalla Awidi
Objectives: This study aimed to optimize WS6-loaded nanoparticles (NPs) with favorable therapeutic properties, including appropriate size, low toxicity, high encapsulation efficiency, and enhanced biocompatibility, for selective cancer targeting and regenerative applications. Methods: Three formulations were investigated: solid lipid nanoparticles (SLNs), polycaprolactone (PCL)-based NPs, and Eudragit RS100-based NPs via microfluidic synthesis. Their physicochemical properties were assessed, followed by biological evaluation on normal cells—dental-derived stem cells (DSCs), gingival fibroblasts (GFs), and human dermal fibroblasts (HDFs)—and cancer cell lines MDA-231 and HepG2. Assays included MTT for viability, apoptosis/necrosis, cell cycle analysis, ROS detection, and cytokine profiling. Results: SLNs showed inherent toxicity despite improved viability upon WS6 loading. PCL NPs improved encapsulation and compatibility but lacked stability. The microfluidic RS-WS6 NPs exhibited optimal characteristics, significantly enhancing viability in normal cells and selectively inducing apoptosis in cancer cells. At 1 µM, RS-WS6 NPs reduced ROS in normal cells (p < 0.05) and increased it in cancer cells (p < 0.05). Cytokine analysis revealed significant downregulation of IL-6, IL-12p70, and TNF-α (p < 0.05), indicating immunomodulatory potential. Conclusions: RS-WS6 NPs developed via microfluidics offer a promising therapeutic platform with selective cytotoxicity against cancer cells, minimal toxicity to normal cells, and anti-inflammatory properties, supporting their use in targeted therapy and regenerative medicine.

13 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMuhammad Alzweiri
Muhammad Alzweiri
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
NQNidal Qinna
Nidal Qinna
GAGhayda' Aldabet
Ghayda' Aldabet
TKThaqif El Khassawna
Thaqif El Khassawna
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Despite substantial progress in biomarker discovery and multi-omics profiling, several features of Alzheimer’s disease (AD), including prolonged compensated states, heterogeneous clinical trajectories, and marked stage-dependent therapeutic responses, remain difficult to integrate into a single mechanistic framework. In this review, we propose an integrative and testable conceptual framework that reframes AD as a single, progressive multi-layer network disorder whose dynamics arise from hierarchical constraint propagation and progressive loss of cross-scale coordination. Integrating evidence from human genetics, epigenomics, transcriptomics, proteomics, metabolomics, spatial biology, connectomics, and longitudinal biomarker studies, we examine how molecular, cellular, and circuit-level processes interact over time to shape disease progression. Within this framework, different omics measurements are interpreted as complementary representations of disease-related changes, rather than as independent molecular signatures. Disease progression reflects the gradual convergence of immune, metabolic, proteostatic, cytoskeletal, and synaptic stress, with overt cognitive impairment emerging when compensatory capacity is exceeded, producing threshold-like network destabilization. By explicitly linking biological scale, temporal hierarchy, and network structure, this synthesis extends prior network-medicine, connectomic, and multi-omics approaches into a testable framework for state-aware stratification, integrative analysis, and stage-appropriate therapeutic investigation in AD.